(Q33859857)

English

CA125 in ovarian cancer

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

CA125 in ovarian cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

1 reference

based on heuristic

inferred from title

author name string

Nathalie Scholler

1

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Nicole Urban

2

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

publication date

1 December 2007

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Biomarkers in Medicine

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

513-523

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

The discovery of prostate-specific antigen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2872496

5 July 2018

Tolerance signaling molecules and pregnancy: IDO, galectins, and the renaissance of regulatory T cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2872496

5 July 2018

Regulatory T cells and regulatory natural killer (NK) cells play important roles in feto-maternal tolerance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2872496

5 July 2018

Development and in vitro validation of anti-mesothelin biobodies that prevent CA125/Mesothelin-dependent cell attachment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2872496

5 July 2018

Peritoneal lavage CEA/CA125 is a prognostic factor for gastric cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2872496

5 July 2018

The distal fallopian tube: a new model for pelvic serous carcinogenesis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2872496

5 July 2018

A candidate precursor to serous carcinoma that originates in the distal fallopian tube.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2872496

5 July 2018

Mesothelin-MUC16 binding is a high affinity, N-glycan dependent interaction that facilitates peritoneal metastasis of ovarian tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2872496

5 July 2018

Phase I study of abagovomab in patients with epithelial ovarian, fallopian tube, or primary peritoneal cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2872496

5 July 2018

Effect of tumor-derived cytokines and growth factors on differentiation and immune suppressive features of myeloid cells in cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2872496

5 July 2018

CA125 expression in spontaneous ovarian adenocarcinomas from laying hens

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2872496

5 July 2018

Tumor-driven evolution of immunosuppressive networks during malignant progression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2872496

5 July 2018

Peritoneal tuberculosis mimicking advanced ovarian cancer: a retrospective review of 22 cases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2872496

5 July 2018

Development of a CA125-mesothelin cell adhesion assay as a screening tool for biologics discovery

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2872496

5 July 2018

Bead-based ELISA for validation of ovarian cancer early detection markers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2872496

5 July 2018

Cancer statistics, 2006

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2872496

5 July 2018

Distinct evolution of the human carcinoma-associated transmembrane mucins, MUC1, MUC4 AND MUC16.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2872496

5 July 2018

New tumor markers: CA125 and beyond.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2872496

5 July 2018

Molecular phenotyping of human endometrium distinguishes menstrual cycle phases and underlying biological processes in normo-ovulatory women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2872496

5 July 2018

Potent suppression of natural killer cell response mediated by the ovarian tumor marker CA125.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2872496

5 July 2018

Complement-inhibiting effect of ovarian cancer antigen CA-125.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2872496

5 July 2018

Soluble mesothelin-related protein--a blood test for mesothelioma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2872496

5 July 2018

Molecular forms and microheterogeneity of the oligosaccharide chains of pregnancy-associated CA125 antigen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2872496

5 July 2018

The immunomodulatory protein B7-H4 is overexpressed in breast and ovarian cancers and promotes epithelial cell transformation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2872496

5 July 2018

The role of ultrasound evaluation in the detection of early-stage epithelial ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2872496

5 July 2018

BRCA1 mutations in ovarian cancer and borderline tumours in Norway: a nested case-control study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2872496

5 July 2018

Human kallikrein 11: an indicator of favorable prognosis in ovarian cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2872496

5 July 2018

Immunotherapy of ovarian cancer with antibodies: a focus on oregovomab

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2872496

5 July 2018

Serum CA125: a tumor marker for monitoring response to treatment and follow-up in patients with non-Hodgkin's lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2872496

5 July 2018

Progress and challenges in screening for early detection of ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2872496

5 July 2018

Solution structure of the SEA domain from the murine homologue of ovarian cancer antigen CA125 (MUC16)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2872496

5 July 2018

Highly expressed genes in pancreatic ductal adenocarcinomas: a comprehensive characterization and comparison of the transcription profiles obtained from three major technologies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2872496

5 July 2018

Binding of ovarian cancer antigen CA125/MUC16 to mesothelin mediates cell adhesion

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2872496

5 July 2018

Expression of CA-125 by progestational bovine endometrium: prospective regulation and function

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2872496

5 July 2018

A parametric empirical Bayes method for cancer screening using longitudinal observations of a biomarker

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2872496

5 July 2018

The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2872496

5 July 2018

Biologic and Immunologic Therapies for Ovarian Cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2872496

5 July 2018

Characterization of the oligosaccharides associated with the human ovarian tumor marker CA125

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2872496

5 July 2018

Tissue polypeptide antigen (TPA), hyaluronan and CA 125 as serum markers in malignant mesothelioma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2872496

5 July 2018

The cancer antigen CA125 represents a novel counter receptor for galectin-1.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2872496

5 July 2018

Ovarian cancer antigen CA125 is encoded by the MUC16 mucin gene

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2872496

5 July 2018

Generating longitudinal screening algorithms using novel biomarkers for disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2872496

5 July 2018

The CA 125 gene: an extracellular superstructure dominated by repeat sequences

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2872496

5 July 2018

Molecular cloning of the CA125 ovarian cancer antigen: identification as a new mucin, MUC16.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2872496

5 July 2018

Precursor lesions of ovarian epithelial malignancy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2872496

5 July 2018

Synthesis and secretion of the ovarian cancer antigen CA 125 by the human cancer cell line NIH:OVCAR-3.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2872496

5 July 2018

Siglec-9, a novel sialic acid binding member of the immunoglobulin superfamily expressed broadly on human blood leukocytes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2872496

5 July 2018

CA-125 levels are related to the likelihood of pregnancy after in vitro fertilization and embryo transfer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2872496

5 July 2018

Increased CA 125 serum levels in patients with advanced acute leukemia with serosal involvement

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2872496

5 July 2018

Soluble member(s) of the mesothelin/megakaryocyte potentiating factor family are detectable in sera from patients with ovarian carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2872496

5 July 2018

Serum CA 125 levels in children with non-Hodgkin's lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2872496

5 July 2018

CA 125 in benign gynecological conditions.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2872496

5 July 2018

CA 125--epitopes and molecular size.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2872496

5 July 2018

More than 15 years of CA 125: what is known about the antigen, its structure and its function.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2872496

5 July 2018

Screening for ovarian cancer: a pilot randomised controlled trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2872496

5 July 2018

Use of a stochastic simulation model to identify an efficient protocol for ovarian cancer screening

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2872496

5 July 2018

Early detection of familial ovarian cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2872496

5 July 2018

Immunohistochemical characterization of 22 monoclonal antibodies against the CA125 antigen: 2nd report from the ISOBM TD-1 Workshop

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2872496

5 July 2018

Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2872496

5 July 2018

Bisecting N-acetylglucosamine on K562 cells suppresses natural killer cytotoxicity and promotes spleen colonization

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2872496

5 July 2018

CA 125 in gynecological pathology--a review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2872496

5 July 2018

Raised serum CA125 level in leiomyoma and leiomyosarcoma of gastrointestinal origin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2872496

5 July 2018

Galectins. Structure and function of a large family of animal lectins

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2872496

5 July 2018

Prognostic value in predicting overall survival of two mucinous markers: CA 15-3 and CA 125 in breast cancer patients at first relapse of disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2872496

5 July 2018

The SEA module: a new extracellular domain associated with O-glycosylation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2872496

5 July 2018

Glycophorin A protects K562 cells from natural killer cell attack. Role of oligosaccharides.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2872496

5 July 2018

Reactivity of a monoclonal antibody with human ovarian carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2872496

5 July 2018

A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2872496

5 July 2018

Occurrence of the mucinous differentiation antigen CA125 in genital tract and conductive airway epithelia of diverse mammalian species (rabbit, dog, monkey).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2872496

5 July 2018

Serum CA 125 as a prognostic factor in non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.4.513

21 January 2018

Maternal serum CA 125 is of prognostic value in patients with uterine bleeding in the detection of small-for-gestational-age neonates.

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.4.513

21 January 2018

Apoptosis of T cells mediated by galectin-1.

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.4.513

21 January 2018

Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship.

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.4.513

21 January 2018

The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome.

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.4.513

21 January 2018

The second generation CA 125 assays.

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.4.513

21 January 2018

Screening for familial ovarian cancer: failure of current protocols to detect ovarian cancer at an early stage according to the international Federation of gynecology and obstetrics system.

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.4.513

21 January 2018

Calculation of the risk of ovarian cancer from serial CA-125 values for preclinical detection in postmenopausal women

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.4.513

21 January 2018

Preoperative sensitivity and specificity for early-stage ovarian cancer when combining cancer antigen CA-125II, CA 15-3, CA 72-4, and macrophage colony-stimulating factor using mixtures of multivariate normal distributions.

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.4.513

21 January 2018

Prospective study using the risk of ovarian cancer algorithm to screen for ovarian cancer.

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.4.513

21 January 2018

Anti-idiotype induction therapy: anti-CA125 antibodies (Ab3) mediated tumor killing in patients treated with Ovarex mAb B43.13 (Ab1).

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.4.513

21 January 2018

Activating anti-idiotypic human anti-mouse antibodies for immunotherapy of ovarian carcinoma.

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.4.513

21 January 2018

Randomized, placebo-controlled study of oregovomab for consolidation of clinical remission in patients with advanced ovarian cancer

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.4.513

21 January 2018

Vaccination of patients with advanced ovarian carcinoma with the anti-idiotype ACA125: immunological response and survival (phase Ib/II).

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.4.513

21 January 2018

Armed antibodies targeting the mucin repeats of the ovarian cancer antigen, MUC16, are highly efficacious in animal tumor models

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.4.513

21 January 2018

Vertebral tuberculosis presenting with elevated CA-125 and weight loss mimicking ovarian malignancy; case report.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2872496

29 October 2018

Interleukin-6 fused to an anti-idiotype antibody in a vaccine increases the specific humoral immune response against CA125+ (MUC-16) ovarian cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2872496

29 October 2018

Evaluation of serum CA 125 concentrations as predictors of pregnancy with human in vitro fertilization.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2872496

29 October 2018

CA 125: The End of the Beginning

1 reference

https://api.crossref.org/works/10.2217%2F17520363.1.4.513

21 January 2018

Toward understanding the natural history of ovarian carcinoma development: a clinicopathological approach

1 reference

https://pubmed.ncbi.nlm.nih.gov/20477371

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preoperative tumor marker CA125 levels in relation to epithelial ovarian cancer stage

1 reference

https://pubmed.ncbi.nlm.nih.gov/20477371

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular nature and possible presence of a membranous glycan-phosphatidylinositol anchor of CA125 antigen

1 reference

https://pubmed.ncbi.nlm.nih.gov/20477371

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Usefulness and limits of CA-125 in diagnosis of endometriosis without associated ovarian endometriomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/20477371

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical course of ovarian cancer patients under repeated stimulation of HAMA using MAb OC125 and B43.13

1 reference

https://pubmed.ncbi.nlm.nih.gov/20477371

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

OVX1, macrophage-colony stimulating factor, and CA-125-II as tumor markers for epithelial ovarian carcinoma: a critical appraisal

1 reference

https://pubmed.ncbi.nlm.nih.gov/20477371

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Elevation of serum and ascites cancer antigen 125 levels in patients with liver cirrhosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20477371

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cancer antigen 125 is produced by human endometrial stromal cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/20477371

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Peritoneal natural killer cells from epithelial ovarian cancer patients show an altered phenotype and bind to the tumour marker MUC16 (CA125)

1 reference

https://pubmed.ncbi.nlm.nih.gov/20477371

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A prostate antigen in sera of prostatic cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/20477371

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The significance of CA125 levels in patients with chronic congestive heart failure. Correlation with clinical and echocardiographic parameters

1 reference

https://pubmed.ncbi.nlm.nih.gov/20477371

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biology of epithelial ovarian cancer: implications for screening women at high genetic risk

1 reference

https://pubmed.ncbi.nlm.nih.gov/20477371

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epitopes on CA 125 from cervical mucus and ascites fluid and characterization of six new antibodies. Third report from the ISOBM TD-1 workshop

1 reference

https://pubmed.ncbi.nlm.nih.gov/20477371

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characterization of antibodies to CA 125 that bind preferentially to the cell-associated form of the antigen

1 reference

https://pubmed.ncbi.nlm.nih.gov/20477371

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor Markers in Ovarian Malignancies

1 reference

https://pubmed.ncbi.nlm.nih.gov/20477371

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunological responses to the tumor-associated antigen CA125 in patients with advanced ovarian cancer induced by the murine monoclonal anti-idiotype vaccine ACA125

1 reference

https://pubmed.ncbi.nlm.nih.gov/20477371

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The combined elevation of tumor markers CA 19-9 and CA 125 in liver disease patients is highly specific for severe liver fibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20477371

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunological consolidation of ovarian carcinoma recurrences with monoclonal anti-idiotype antibody ACA125: immune responses and survival in palliative treatment. See The biology behind: K. A. Foon and M. Bhattacharya-Chatterjee, Are solid tumor ant

1 reference

https://pubmed.ncbi.nlm.nih.gov/20477371

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum CA-125 in Relation to Adnexal Dysplasia and Cancer in Women at Hereditary High Risk of Ovarian Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20477371

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CA125 and transvaginal ultrasound monitoring in high-risk women cannot prevent the diagnosis of advanced ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20477371

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The use of the monoclonal antibody mesothelin in the diagnosis of malignant mesothelioma in pleural biopsies

1 reference

https://pubmed.ncbi.nlm.nih.gov/20477371

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monoclonal antibody immunoradiometric assay for an antigenic determinant (CA 125) associated with human epithelial ovarian carcinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/20477371

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum CA-125 in preoperative patients at high risk for endometriosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20477371

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CA125 Serum levels in tubercolosis patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/20477371

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Elevated CA125 in breast cancer--A sign of advanced disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/20477371

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chylous ascites with marked elevation of CA-125 in cirrhosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20477371

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dissociation in serum CA125 concentrations measured by different monoclonal antibodies

1 reference

https://pubmed.ncbi.nlm.nih.gov/20477371

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CA-125 in peritoneal fluid from patients with nonmalignant gynecologic disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/20477371

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Peritoneal tuberculosis with pelvic abdominal mass, ascites and elevated CA 125 mimicking advanced ovarian carcinoma: a series of 10 cases

1 reference

https://pubmed.ncbi.nlm.nih.gov/20477371

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Maternal CA-125 levels in pregnancy and the puerperium

1 reference

https://pubmed.ncbi.nlm.nih.gov/20477371

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum CA 125 is of clinical value in the staging and follow-up of patients with non-Hodgkin's lymphoma: correlation with tumor parameters and disease activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/20477371

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical value of a new serum tumor marker, CA125II, in gynecologic disease: comparison with CA125

1 reference

https://pubmed.ncbi.nlm.nih.gov/20477371

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Elevated serum CA 125 levels prior to diagnosis of ovarian neoplasia: relevance for early detection of ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20477371

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor markers in endometriosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20477371

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor necrosis factor-alpha-related intraperitoneal release of CA 125 in cirrhotic patients with sterile ascites

1 reference

https://pubmed.ncbi.nlm.nih.gov/20477371

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mesothelin is overexpressed in pancreaticobiliary adenocarcinomas but not in normal pancreas and chronic pancreatitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20477371

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Specificity and Affinity of 26 Monoclonal Antibodies against the CA 125 Antigen: First Report from the ISOBM TD-1 Workshop

1 reference

https://pubmed.ncbi.nlm.nih.gov/20477371

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CA125- and tumor-specific T-cell responses correlate with prolonged survival in oregovomab-treated recurrent ovarian cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/20477371

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Elevated CA 125 in chronic liver disease with ascites]

1 reference

https://pubmed.ncbi.nlm.nih.gov/20477371

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fluctuations in CA 125 and CA 15-3 serum concentrations during spontaneous ovulatory cycles

1 reference

https://pubmed.ncbi.nlm.nih.gov/20477371

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction of CA125-specific B and T cell responses in patients injected with MAb-B43.13--evidence for antibody-mediated antigen-processing and presentation of CA125 in vivo

1 reference

https://pubmed.ncbi.nlm.nih.gov/20477371

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Isolation and characterization of ovarian cancer antigen CA 125 using a new monoclonal antibody (VK-8): identification as a mucin-type molecule

1 reference

https://pubmed.ncbi.nlm.nih.gov/20477371

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2217/17520363.1.4.513

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33859857&oldid=1533304359"